Back to companies

Rocket Pharmaceuticals Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Rocket Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
WO2023205767A3 Application B-cell lymphoma 2–associated anthanogene 3 (BAG3) gene therapy using aav vector C12N15/86; C12N2750/14143; C12N2830/008; C12N2830/48; A61K48/00; C07K14/47 November 30, 2023
WO2023205767A2 Application B-cell lymphoma 2–associated anthanogene 3 (BAG3) gene therapy using aav vector C12N15/86; C12N2750/14143; C12N2830/008; C12N2830/48; A61K48/00; C07K14/47 October 26, 2023
EP4255458A1 Application Traitement de la maladie de danon C12N2750/14143; A01K2207/25; A01K2217/075; A01K2227/105; A01K2267/0375; A61K31/4412; A61K31/57; A61K38/1709; A61K39/395; A61K48/005; A61K48/0058; A61K48/0075; A61K48/0083; A61P3/00; A61P43/00; C07K14/70596 October 11, 2023
WO2023154763A3 Application Adeno-associated viral vector for glut1 expression and uses thereof C12N15/86; C12N2750/14122; C12N2750/14143; C12N2750/14145; C12N2830/008; C12N2830/48; C12N2830/50; A61K38/00; A61K48/005; A61K48/0058; C07K14/005; C07K14/705 September 28, 2023
KR1020230129431A Application 다농병의 치료 C12N2750/14143; A01K2207/25; A01K2217/075; A01K2227/105; A01K2267/0375; A61K31/4412; A61K31/57; A61K38/1709; A61K39/395; A61K48/005; A61K48/0058; A61K48/0075; A61K48/0083; A61P3/00; A61P43/00; C07K14/70596 September 08, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Register your interest

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer